The Senate’s quiet approval of the federal pharmacare bill might not have the fireworks of an election night, but make no mistake: this is a landmark moment for Canadian health care. For decades, universal prescription coverage has been the missing piece in our cherished public system. Now, with this legislation set to become law, that gap is finally starting to close.
This bill is more than political theatre. It’s the practical outcome of the now-defunct supply-and-confidence deal between the Liberals and the NDP a partnership that often drew skepticism but undeniably pushed pharmacare forward. The careful wording reflects months of negotiation, and its passage shows that when political rivals find common ground, Canadians can win.
The first tangible benefits will be felt by those managing diabetes and by people seeking birth control. These are not small victories. Insulin and contraceptives are essentials, not luxuries, and making them universally accessible will ease the financial burden on thousands of households.
Of course, the work is far from done. Health Minister Mark Holland faces the tough task of getting every province and territory to sign on by next spring. British Columbia has already stepped up with a memorandum of understanding, but others will surely haggle over funding and control. That’s politics.
Still, this moment deserves recognition. Royal assent will be the final formality, but the message is already clear: universal pharmacare is no longer a pipe dream. It’s becoming policy. Canadians should hold their governments to this promise and push for a comprehensive plan that covers everyone, everywhere, for the medicines they need. After all, what good is a public health system if it stops at the pharmacy counter?
